Nurse Practitioner, Family · Flowood, MS
NPI
1649463050
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2510 Lakeland Dr
Flowood, MS, 39232
Phone (601) 355-1234
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
1,939 services
Medicare patients, 2024
278
Average age 71
Drug cost, 2024
$2.3M
400 prescriptions
Company payments, 2025
$12K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tina M Gregg was code 99214 (office e&m - established), 338 times for 238 patients. In total Tina M Gregg billed 1,939 services in 38 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 338 | 238 | $66.20 | $22K |
| 80076 Clinical Chemistry | Office | 154 | 136 | $7.94 | $1,223 |
| 80053 Clinical Chemistry | Office | 142 | 90 | $10.30 | $1,462 |
| 85027 Blood Count | Office | 130 | 88 | $6.27 | $815 |
| 76705 Ultrasound - Abdomen and Pelvis | Office | 122 | 82 | $33.37 | $4,071 |
| 82105 Clinical Chemistry | Office | 119 | 75 | $16.32 | $1,942 |
| 76981 Ultrasound - Nonspecific | Office | 112 | 110 | $58.90 | $6,597 |
| 91200 Standard X-ray | Office | 46 | 46 | $10.43 | $480 |
| 99213 Office E&M - Established | Office | 29 | 29 | $43.78 | $1,270 |
| 87340 Immunoassay | Office | 18 | 17 | $9.71 | $175 |
| 85025 Blood Count | Office | 16 | 12 | $7.61 | $122 |
| 86704 Immunoassay | Office | 15 | 15 | $11.81 | $177 |
| 86708 Immunoassay | Office | 13 | 13 | $12.14 | $158 |
| 82728 Clinical Chemistry | Office | 12 | 12 | $12.65 | $152 |
| 84466 Clinical Chemistry | Office | 12 | 12 | $11.72 | $141 |
By year: 2022 $41K for 1,425 services; 2023 $71K for 3,734 services; 2024 $53K for 1,939 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80076 Clinical Chemistry | 154 | 136 | $7.94 | $1,223 |
| 80053 Clinical Chemistry | 142 | 90 | $10.30 | $1,462 |
| 85027 Blood Count | 130 | 88 | $6.27 | $815 |
| 82105 Clinical Chemistry | 119 | 75 | $16.32 | $1,942 |
| 87340 Immunoassay | 18 | 17 | $9.71 | $175 |
| 85025 Blood Count | 16 | 12 | $7.61 | $122 |
| 86704 Immunoassay | 15 | 15 | $11.81 | $177 |
| 86708 Immunoassay | 13 | 13 | $12.14 | $158 |
| 84466 Clinical Chemistry | 12 | 12 | $11.72 | $141 |
| 83540 Clinical Chemistry | 12 | 12 | $6.03 | $72.35 |
Medicare prescription drug claims, 2024
In 2024, the drug Tina M Gregg prescribed most often to Medicare patients was Epclusa (Sofosbuvir/Velpatasvir), with 80 prescriptions and refills. In total Tina M Gregg wrote 400 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Epclusa Sofosbuvir/Velpatasvir | 80 | 80 | 25 | $2.0M |
| Entecavir Generic | 70 | 76 | Under 11 | $10K |
| Tenofovir Disoproxil Fumarate Generic | 55 | 76 | Under 11 | $7,312 |
| Xifaxan Rifaximin | 31 | 31 | Under 11 | $102K |
| Spironolactone Generic | 18 | 36 | Under 11 | $110 |
| Omeprazole Generic | 17 | 37 | Under 11 | $212 |
| Rezdiffra Resmetirom | 15 | 15 | Under 11 | $59K |
Brand drugs: 164 claims; generic drugs: 236 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tina M Gregg $12K ($12K in general payments such as food, travel and fees) from 14 companies. The largest payer was Madrigal Pharmaceuticals with $11K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 35 | $11K |
| Abbvie Inc. ABBV | 3 | $255 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 6 | $179 |
| Janssen Biotech, Inc. JNJ | 2 | $148 |
| Novo Nordisk Inc NVO | 2 | $93.68 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $65.67 |
| Fujifilm Healthcare Americas Corporation | 1 | $47.03 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $42.09 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $41.73 |
| Intercept Pharmaceuticals, Inc. | 2 | $36.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.